Medical experts come together to share their views in this on-demand webinar replay of an interactive online discussion:
New Oral Endocrine Therapy Options for Patients with Advanced or Metastatic ER+ Breast Cancer
The independent expert panel discussed oral SERDs efficacy and safety profiles in patients with ER+/HER2- advanced or metastatic breast cancer and their place in the treatment landscape
They also covered how to optimise treatment selection and sequencing in ER+/HER2- advanced or metastatic breast cancer and why, when and how to test for ESR1 mutation
The event concluded with speakers and participants engaging in a Q&A to address pressing questions
Watch the replay, broken down into 4 digestible videos, download the accompanying slides, and take the accredited e-learning using the blue button below the videos.